The Goldman Consensus statement on depression in multiple sclerosis

Randolph B. Schiffer; Peter Arnett; Aliza Ben-Zacharia; Ralph Benedict; Julie Bobholz; Lauren Caruso; Gordon Chelune; Darcy Cox; Gary Cutter; Terry DiLorenzo; John DeLuca; Jane Epstein; Anthony Feinstein; Stephen J. Ferrando; Jill Fischer; Fred Foley; Carl Granger; June Halper; Nancy Holland; Jeffery Kocsis; Rosalind Kalb; Nicholas LaRocca; Fred Lublin; Aaron Miller; Deborah Miller; Sarah Minden; David C. Mohr; Linda Morgante; Marie Namey; Scott B. Patten

doi:10.1191/1352458505ms1162oa

The Goldman Consensus statement on depression in multiple sclerosis

Randolph B. Schiffer, Peter Arnett, Aliza Ben-Zacharia, Ralph Benedict, Julie Bobholz, Lauren Caruso, Gordon Chelune, Darcy Cox, Gary Cutter, Terry DiLorenzo, John DeLuca, Jane Epstein, Anthony Feinstein, Stephen J. Ferrando, Jill Fischer, Fred Foley, Carl Granger, June Halper, Nancy Holland, Jeffery KocsisRosalind Kalb, Nicholas LaRocca, Fred Lublin, Aaron Miller, Deborah Miller, Sarah Minden, David C. Mohr, Linda Morgante, Marie Namey, Scott B. Patten

Research output: Contribution to journal › Review article › peer-review

263 Scopus citations

Abstract

Background. In January 2002 the New York City Chapter of the National Multiple Sclerosis Society convened a panel of experts to review the issue of depressive affective disorders associated with multiple sclerosis (MS). This Consensus Conference was supported by a grant from the Goldman family of New York City. Results. The panel reviewed summaries of current epidemiologic, neurobiologic, and therapeutic studies having to do with depressive disorders among MS patient populations. Depressive disorders occur at high rates among patients with MS, and there is reason to believe that the immunopathology of the disease is involved in the clinical expression of affective disorders. The depressive syndromes of MS have a major negative impact on quality of life for MS sufferers, but are treatable. At the present time, most MS patients with depression do not receive adequate recognition and treatment. Conclusions. The Goldman Consensus Conference Study Group provides recommendations for improved screening, diagnosis, and clinical management for depressive affective disorders among patients suffering from MS.

Original language	English
Pages (from-to)	328-337
Number of pages	10
Journal	Multiple Sclerosis Journal
Volume	11
Issue number	3
DOIs	https://doi.org/10.1191/1352458505ms1162oa
State	Published - Jun 2005

Keywords

Affective disorders
Cognition
Depression
Multiple sclerosis
Neuropsychiatry

Access to Document

10.1191/1352458505ms1162oa

Cite this

Schiffer, R. B., Arnett, P., Ben-Zacharia, A., Benedict, R., Bobholz, J., Caruso, L., Chelune, G., Cox, D., Cutter, G., DiLorenzo, T., DeLuca, J., Epstein, J., Feinstein, A., Ferrando, S. J., Fischer, J., Foley, F., Granger, C., Halper, J., Holland, N., ... Patten, S. B. (2005). The Goldman Consensus statement on depression in multiple sclerosis. Multiple Sclerosis Journal, 11(3), 328-337. https://doi.org/10.1191/1352458505ms1162oa

@article{d9134f6b0987489bb1c3f7df8d0a47b4,

title = "The Goldman Consensus statement on depression in multiple sclerosis",

abstract = "Background. In January 2002 the New York City Chapter of the National Multiple Sclerosis Society convened a panel of experts to review the issue of depressive affective disorders associated with multiple sclerosis (MS). This Consensus Conference was supported by a grant from the Goldman family of New York City. Results. The panel reviewed summaries of current epidemiologic, neurobiologic, and therapeutic studies having to do with depressive disorders among MS patient populations. Depressive disorders occur at high rates among patients with MS, and there is reason to believe that the immunopathology of the disease is involved in the clinical expression of affective disorders. The depressive syndromes of MS have a major negative impact on quality of life for MS sufferers, but are treatable. At the present time, most MS patients with depression do not receive adequate recognition and treatment. Conclusions. The Goldman Consensus Conference Study Group provides recommendations for improved screening, diagnosis, and clinical management for depressive affective disorders among patients suffering from MS.",

keywords = "Affective disorders, Cognition, Depression, Multiple sclerosis, Neuropsychiatry",

author = "Schiffer, {Randolph B.} and Peter Arnett and Aliza Ben-Zacharia and Ralph Benedict and Julie Bobholz and Lauren Caruso and Gordon Chelune and Darcy Cox and Gary Cutter and Terry DiLorenzo and John DeLuca and Jane Epstein and Anthony Feinstein and Ferrando, {Stephen J.} and Jill Fischer and Fred Foley and Carl Granger and June Halper and Nancy Holland and Jeffery Kocsis and Rosalind Kalb and Nicholas LaRocca and Fred Lublin and Aaron Miller and Deborah Miller and Sarah Minden and Mohr, {David C.} and Linda Morgante and Marie Namey and Patten, {Scott B.}",

year = "2005",

month = jun,

doi = "10.1191/1352458505ms1162oa",

language = "English",

volume = "11",

pages = "328--337",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "3",

}

Schiffer, RB, Arnett, P, Ben-Zacharia, A, Benedict, R, Bobholz, J, Caruso, L, Chelune, G, Cox, D, Cutter, G, DiLorenzo, T, DeLuca, J, Epstein, J, Feinstein, A, Ferrando, SJ, Fischer, J, Foley, F, Granger, C, Halper, J, Holland, N, Kocsis, J, Kalb, R, LaRocca, N, Lublin, F , Miller, A, Miller, D, Minden, S, Mohr, DC, Morgante, L, Namey, M & Patten, SB 2005, 'The Goldman Consensus statement on depression in multiple sclerosis', Multiple Sclerosis Journal, vol. 11, no. 3, pp. 328-337. https://doi.org/10.1191/1352458505ms1162oa

TY - JOUR

T1 - The Goldman Consensus statement on depression in multiple sclerosis

AU - Schiffer, Randolph B.

AU - Arnett, Peter

AU - Ben-Zacharia, Aliza

AU - Benedict, Ralph

AU - Bobholz, Julie

AU - Caruso, Lauren

AU - Chelune, Gordon

AU - Cox, Darcy

AU - Cutter, Gary

AU - DiLorenzo, Terry

AU - DeLuca, John

AU - Epstein, Jane

AU - Feinstein, Anthony

AU - Ferrando, Stephen J.

AU - Fischer, Jill

AU - Foley, Fred

AU - Granger, Carl

AU - Halper, June

AU - Holland, Nancy

AU - Kocsis, Jeffery

AU - Kalb, Rosalind

AU - LaRocca, Nicholas

AU - Lublin, Fred

AU - Miller, Aaron

AU - Miller, Deborah

AU - Minden, Sarah

AU - Mohr, David C.

AU - Morgante, Linda

AU - Namey, Marie

AU - Patten, Scott B.

PY - 2005/6

Y1 - 2005/6

N2 - Background. In January 2002 the New York City Chapter of the National Multiple Sclerosis Society convened a panel of experts to review the issue of depressive affective disorders associated with multiple sclerosis (MS). This Consensus Conference was supported by a grant from the Goldman family of New York City. Results. The panel reviewed summaries of current epidemiologic, neurobiologic, and therapeutic studies having to do with depressive disorders among MS patient populations. Depressive disorders occur at high rates among patients with MS, and there is reason to believe that the immunopathology of the disease is involved in the clinical expression of affective disorders. The depressive syndromes of MS have a major negative impact on quality of life for MS sufferers, but are treatable. At the present time, most MS patients with depression do not receive adequate recognition and treatment. Conclusions. The Goldman Consensus Conference Study Group provides recommendations for improved screening, diagnosis, and clinical management for depressive affective disorders among patients suffering from MS.

AB - Background. In January 2002 the New York City Chapter of the National Multiple Sclerosis Society convened a panel of experts to review the issue of depressive affective disorders associated with multiple sclerosis (MS). This Consensus Conference was supported by a grant from the Goldman family of New York City. Results. The panel reviewed summaries of current epidemiologic, neurobiologic, and therapeutic studies having to do with depressive disorders among MS patient populations. Depressive disorders occur at high rates among patients with MS, and there is reason to believe that the immunopathology of the disease is involved in the clinical expression of affective disorders. The depressive syndromes of MS have a major negative impact on quality of life for MS sufferers, but are treatable. At the present time, most MS patients with depression do not receive adequate recognition and treatment. Conclusions. The Goldman Consensus Conference Study Group provides recommendations for improved screening, diagnosis, and clinical management for depressive affective disorders among patients suffering from MS.

KW - Affective disorders

KW - Cognition

KW - Depression

KW - Multiple sclerosis

KW - Neuropsychiatry

UR - http://www.scopus.com/inward/record.url?scp=20144384545&partnerID=8YFLogxK

U2 - 10.1191/1352458505ms1162oa

DO - 10.1191/1352458505ms1162oa

M3 - Review article

C2 - 15957516

AN - SCOPUS:20144384545

SN - 1352-4585

VL - 11

SP - 328

EP - 337

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - 3

ER -

The Goldman Consensus statement on depression in multiple sclerosis

Abstract

Keywords

Access to Document

Fingerprint

Cite this